Skip to main content
Caplight Logo









Illumacell Inc.

Illumacell Inc.

Private
Hamilton, OntarioHealthcare & Life Scienceshttps://www.illumacell.com/

Last Round

Seed

Sep 27, 2022

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Illumacell Inc. is a scientific research and development services company that has developed a novel manufacturing platform that enables cost-effective and scalable production of cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Usage-Based SaaS, Government Contracts

AI Layer

Non-AI

Keywords

photodynamic therapyPDTnon-invasive cancer treatmentmedical devicesolid tumor treatmentlight therapy for cancerWall-of-Lightdeep tissue therapyLED medical deviceclinical stage medtechoral cancer treatmentOral Potentially Malignant DisordersOPMDsphotosensitizerspecial access program

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Illumacell Inc. Comparables

Compare Illumacell Inc. with similar companies based on industry and business-model similarity.

Illumacell Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lumeda Inc.
79%
Hemerion Therapeutics
78%
ImPact Biotech
76%

Illumacell Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 27, 2022

Key People

Founding team and executive leadership

Michael Ben

CEO

Executive Team

Illumacell Inc. Investors

Notable investors and investment history

Illumacell Inc. investors
InvestorRounds
The Accelerator CentreSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 185% MoM, reaching 2.2K.

  • Apr 8, 2026

    Monthly visitors increased 543% MoM.

Illumacell Inc. Filings

Explore SEC and related filing metadata, where available.

Illumacell Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Illumacell Inc.'s valuation, stock price, and market status.

Is Illumacell Inc. a public or private company?

Illumacell Inc. is a private company.

What is the current stock price of Illumacell Inc.?

Illumacell Inc. is a private company with no public stock price. Caplight tracks Illumacell Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Illumacell Inc. worth (valuation)?

Valuation information for Illumacell Inc. is not publicly available.

Can I buy Illumacell Inc. stock?

Illumacell Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Illumacell Inc.'s last funding round?

Illumacell Inc.'s most recent funding round was Seed on September 27, 2022.

Who are the main investors in Illumacell Inc.?

Key investors in Illumacell Inc. include The Accelerator Centre.

Will Illumacell Inc. IPO soon?

No public IPO plans have been announced for Illumacell Inc..

How can I track Illumacell Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Illumacell Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHamilton, Ontario
Employee Range3
Year Founded2020
Last FundingSep 27, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?